middle.news
How Is AFT Pharmaceuticals Driving 33% Revenue Growth Amid Global Expansion?
7:41am on Thursday 20th of November, 2025 AEDT
•
Healthcare
Read Story
How Is AFT Pharmaceuticals Driving 33% Revenue Growth Amid Global Expansion?
7:41am on Thursday 20th of November, 2025 AEDT
Key Points
1H FY26 revenue up 33% to NZ$114.9 million
ANZ sales grow 23%, led by Australia’s 31% increase
EBITDA turns positive at NZ$6.6 million from prior loss
Global footprint expands to 85 countries with new launches
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Aft Pharmaceuticals (ASX:AFP)
OPEN ARTICLE